GIST Trial: Treating Glucose Levels Acutely Doesn’t Help Survival, but Does Cause Hypotension

GIST Trial: Treating Glucose Levels Acutely Doesn’t Help Survival, but Does Cause Hypotension

0:00
10 February 2007

CHRISTOPHER GRAY, University of Newcastle REFERENCE: Abstract No. LB2 Treating high blood sugar in the acute phases of stroke doesn’t reduce risk of death or severe disability, the GIST –

Christopher Gray

CHRISTOPHER GRAY, University of Newcastle

REFERENCE: Abstract No. LB2
Treating high blood sugar in the acute phases of stroke doesn’t reduce risk of death or severe disability, the GIST – UK (Glucose Insulin in Stroke Trial) has found. This is despite other trials reporting that high glucose levels are associated with increased risk of stroke. Investigators also found that treating glucose levels aggressively lowered blood pressure. To discuss this surprise result, and the background to the trial, Helen Morant talked to Chris Gray.

[audio:https://www.audiomedica.com/podcasting/cardio/020709_chris_gray.mp3]